TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global PARP Inhibitor Biomarkers Service Market Insights and Forecast to 2028

Global PARP Inhibitor Biomarkers Service Market Insights and Forecast to 2028

  • Category:Life Sciences
  • Published on : 10 June 2022
  • Pages :88
  • Formats:
  • Report Code:SMR-7144850
OfferClick for best price

Best Price: $3920

PARP Inhibitor Biomarkers Service Market Size, Share 2022


Market Analysis and Insights: Global PARP Inhibitor Biomarkers Service Market

The global PARP Inhibitor Biomarkers Service market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global PARP Inhibitor Biomarkers Service market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global PARP Inhibitor Biomarkers Service market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global PARP Inhibitor Biomarkers Service market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global PARP Inhibitor Biomarkers Service market.

Global PARP Inhibitor Biomarkers Service Scope and Market Size

PARP Inhibitor Biomarkers Service market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global PARP Inhibitor Biomarkers Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Segment by Application

  • Hospital
  • Clinic
  • Others

By Company

  • Myriad Genetics, Inc.
  • Hoffmann-La Roche AG
  • Invitae Corporation
  • NeoGenomics Laboratories, Inc.
  • BPS Bioscience, Inc.

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes PARP Inhibitor Biomarkers Service product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of PARP Inhibitor Biomarkers Service, with price, sales, revenue, and global market share of PARP Inhibitor Biomarkers Service from 2019 to 2022.

Chapter 3, the PARP Inhibitor Biomarkers Service competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the PARP Inhibitor Biomarkers Service breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the PARP Inhibitor Biomarkers Service market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of PARP Inhibitor Biomarkers Service.

Chapter 13, 14, and 15, to describe PARP Inhibitor Biomarkers Service sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 PARP Inhibitor Biomarkers Service Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global PARP Inhibitor Biomarkers Service Market Insights and Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 88 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PARP Inhibitor Biomarkers Service Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 BRCA 1 & 2 Testing
1.2.3 HRD Testing
1.2.4 HRR Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global PARP Inhibitor Biomarkers Service Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global PARP Inhibitor Biomarkers Service Market Perspective (2017-2028)
2.2 PARP Inhibitor Biomarkers Service Growth Trends by Region
2.2.1 PARP Inhibitor Biomarkers Service Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 PARP Inhibitor Biomarkers Service Historic Market Size by Region (2017-2022)
2.2.3 PARP Inhibitor Biomarkers Service Forecasted Market Size by Region (2023-2028)
2.3 PARP Inhibitor Biomarkers Service Market Dynamics
2.3.1 PARP Inhibitor Biomarkers Service Industry Trends
2.3.2 PARP Inhibitor Biomarkers Service Market Drivers
2.3.3 PARP Inhibitor Biomarkers Service Market Challenges
2.3.4 PARP Inhibitor Biomarkers Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PARP Inhibitor Biomarkers Service Players by Revenue
3.1.1 Global Top PARP Inhibitor Biomarkers Service Players by Revenue (2017-2022)
3.1.2 Global PARP Inhibitor Biomarkers Service Revenue Market Share by Players (2017-2022)
3.2 Global PARP Inhibitor Biomarkers Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PARP Inhibitor Biomarkers Service Revenue
3.4 Global PARP Inhibitor Biomarkers Service Market Concentration Ratio
3.4.1 Global PARP Inhibitor Biomarkers Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PARP Inhibitor Biomarkers Service Revenue in 2021
3.5 PARP Inhibitor Biomarkers Service Key Players Head office and Area Served
3.6 Key Players PARP Inhibitor Biomarkers Service Product Solution and Service
3.7 Date of Enter into PARP Inhibitor Biomarkers Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PARP Inhibitor Biomarkers Service Breakdown Data by Type
4.1 Global PARP Inhibitor Biomarkers Service Historic Market Size by Type (2017-2022)
4.2 Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Type (2023-2028)
5 PARP Inhibitor Biomarkers Service Breakdown Data by Application
5.1 Global PARP Inhibitor Biomarkers Service Historic Market Size by Application (2017-2022)
5.2 Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America PARP Inhibitor Biomarkers Service Market Size (2017-2028)
6.2 North America PARP Inhibitor Biomarkers Service Market Size by Type
6.2.1 North America PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022)
6.2.2 North America PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028)
6.2.3 North America PARP Inhibitor Biomarkers Service Market Share by Type (2017-2028)
6.3 North America PARP Inhibitor Biomarkers Service Market Size by Application
6.3.1 North America PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022)
6.3.2 North America PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028)
6.3.3 North America PARP Inhibitor Biomarkers Service Market Share by Application (2017-2028)
6.4 North America PARP Inhibitor Biomarkers Service Market Size by Country
6.4.1 North America PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022)
6.4.2 North America PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe PARP Inhibitor Biomarkers Service Market Size (2017-2028)
7.2 Europe PARP Inhibitor Biomarkers Service Market Size by Type
7.2.1 Europe PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022)
7.2.2 Europe PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028)
7.2.3 Europe PARP Inhibitor Biomarkers Service Market Share by Type (2017-2028)
7.3 Europe PARP Inhibitor Biomarkers Service Market Size by Application
7.3.1 Europe PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022)
7.3.2 Europe PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028)
7.3.3 Europe PARP Inhibitor Biomarkers Service Market Share by Application (2017-2028)
7.4 Europe PARP Inhibitor Biomarkers Service Market Size by Country
7.4.1 Europe PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022)
7.4.2 Europe PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size (2017-2028)
8.2 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Type
8.2.1 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022)
8.2.2 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028)
8.2.3 Asia-Pacific PARP Inhibitor Biomarkers Service Market Share by Type (2017-2028)
8.3 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Application
8.3.1 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022)
8.3.2 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028)
8.3.3 Asia-Pacific PARP Inhibitor Biomarkers Service Market Share by Application (2017-2028)
8.4 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Region
8.4.1 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2017-2022)
8.4.2 Asia-Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America PARP Inhibitor Biomarkers Service Market Size (2017-2028)
9.2 Latin America PARP Inhibitor Biomarkers Service Market Size by Type
9.2.1 Latin America PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022)
9.2.2 Latin America PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028)
9.2.3 Latin America PARP Inhibitor Biomarkers Service Market Share by Type (2017-2028)
9.3 Latin America PARP Inhibitor Biomarkers Service Market Size by Application
9.3.1 Latin America PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022)
9.3.2 Latin America PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028)
9.3.3 Latin America PARP Inhibitor Biomarkers Service Market Share by Application (2017-2028)
9.4 Latin America PARP Inhibitor Biomarkers Service Market Size by Country
9.4.1 Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022)
9.4.2 Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size (2017-2028)
10.2 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Type
10.2.1 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022)
10.2.2 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028)
10.2.3 Middle East & Africa PARP Inhibitor Biomarkers Service Market Share by Type (2017-2028)
10.3 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Application
10.3.1 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022)
10.3.2 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028)
10.3.3 Middle East & Africa PARP Inhibitor Biomarkers Service Market Share by Application (2017-2028)
10.4 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Country
10.4.1 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022)
10.4.2 Middle East & Africa PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Myriad Genetics, Inc.
11.1.1 Myriad Genetics, Inc. Company Details
11.1.2 Myriad Genetics, Inc. Business Overview
11.1.3 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Introduction
11.1.4 Myriad Genetics, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022)
11.1.5 Myriad Genetics, Inc. Recent Developments
11.2 Hoffmann-La Roche AG
11.2.1 Hoffmann-La Roche AG Company Details
11.2.2 Hoffmann-La Roche AG Business Overview
11.2.3 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Introduction
11.2.4 Hoffmann-La Roche AG Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022)
11.2.5 Hoffmann-La Roche AG Recent Developments
11.3 Invitae Corporation
11.3.1 Invitae Corporation Company Details
11.3.2 Invitae Corporation Business Overview
11.3.3 Invitae Corporation PARP Inhibitor Biomarkers Service Introduction
11.3.4 Invitae Corporation Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022)
11.3.5 Invitae Corporation Recent Developments
11.4 NeoGenomics Laboratories, Inc.
11.4.1 NeoGenomics Laboratories, Inc. Company Details
11.4.2 NeoGenomics Laboratories, Inc. Business Overview
11.4.3 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Introduction
11.4.4 NeoGenomics Laboratories, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022)
11.4.5 NeoGenomics Laboratories, Inc. Recent Developments
11.5 BPS Bioscience, Inc.
11.5.1 BPS Bioscience, Inc. Company Details
11.5.2 BPS Bioscience, Inc. Business Overview
11.5.3 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Introduction
11.5.4 BPS Bioscience, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022)
11.5.5 BPS Bioscience, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global PARP Inhibitor Biomarkers Service Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of BRCA 1 & 2 Testing
Table 3. Key Players of HRD Testing
Table 4. Key Players of HRR Testing
Table 5. Key Players of Others
Table 6. Global PARP Inhibitor Biomarkers Service Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global PARP Inhibitor Biomarkers Service Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global PARP Inhibitor Biomarkers Service Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global PARP Inhibitor Biomarkers Service Market Share by Region (2017-2022)
Table 10. Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global PARP Inhibitor Biomarkers Service Market Share by Region (2023-2028)
Table 12. PARP Inhibitor Biomarkers Service Market Trends
Table 13. PARP Inhibitor Biomarkers Service Market Drivers
Table 14. PARP Inhibitor Biomarkers Service Market Challenges
Table 15. PARP Inhibitor Biomarkers Service Market Restraints
Table 16. Global PARP Inhibitor Biomarkers Service Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global PARP Inhibitor Biomarkers Service Revenue Share by Players (2017-2022)
Table 18. Global Top PARP Inhibitor Biomarkers Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP Inhibitor Biomarkers Service as of 2021)
Table 19. Ranking of Global Top PARP Inhibitor Biomarkers Service Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by PARP Inhibitor Biomarkers Service Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players PARP Inhibitor Biomarkers Service Product Solution and Service
Table 23. Date of Enter into PARP Inhibitor Biomarkers Service Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Type (2017-2022)
Table 27. Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global PARP Inhibitor Biomarkers Service Revenue Market Share by Type (2023-2028)
Table 29. Global PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global PARP Inhibitor Biomarkers Service Revenue Share by Application (2017-2022)
Table 31. Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global PARP Inhibitor Biomarkers Service Revenue Share by Application (2023-2028)
Table 33. North America PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific PARP Inhibitor Biomarkers Service Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size by Country (2023-2028) & (US$ Million)
Table 63. Myriad Genetics, Inc. Company Details
Table 64. Myriad Genetics, Inc. Business Overview
Table 65. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Product
Table 66. Myriad Genetics, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022) & (US$ Million)
Table 67. Myriad Genetics, Inc. Recent Developments
Table 68. Hoffmann-La Roche AG Company Details
Table 69. Hoffmann-La Roche AG Business Overview
Table 70. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Product
Table 71. Hoffmann-La Roche AG Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022) & (US$ Million)
Table 72. Hoffmann-La Roche AG Recent Developments
Table 73. Invitae Corporation Company Details
Table 74. Invitae Corporation Business Overview
Table 75. Invitae Corporation PARP Inhibitor Biomarkers Service Product
Table 76. Invitae Corporation Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022) & (US$ Million)
Table 77. Invitae Corporation Recent Developments
Table 78. NeoGenomics Laboratories, Inc. Company Details
Table 79. NeoGenomics Laboratories, Inc. Business Overview
Table 80. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Product
Table 81. NeoGenomics Laboratories, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022) & (US$ Million)
Table 82. NeoGenomics Laboratories, Inc. Recent Developments
Table 83. BPS Bioscience, Inc. Company Details
Table 84. BPS Bioscience, Inc. Business Overview
Table 85. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Product
Table 86. BPS Bioscience, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2017-2022) & (US$ Million)
Table 87. BPS Bioscience, Inc. Recent Developments
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PARP Inhibitor Biomarkers Service Market Share by Type: 2021 VS 2028
Figure 2. BRCA 1 & 2 Testing Features
Figure 3. HRD Testing Features
Figure 4. HRR Testing Features
Figure 5. Others Features
Figure 6. Global PARP Inhibitor Biomarkers Service Market Share by Application: 2021 VS 2028
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. PARP Inhibitor Biomarkers Service Report Years Considered
Figure 11. Global PARP Inhibitor Biomarkers Service Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global PARP Inhibitor Biomarkers Service Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global PARP Inhibitor Biomarkers Service Market Share by Region: 2021 VS 2028
Figure 14. Global PARP Inhibitor Biomarkers Service Market Share by Players in 2021
Figure 15. Global Top PARP Inhibitor Biomarkers Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP Inhibitor Biomarkers Service as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by PARP Inhibitor Biomarkers Service Revenue in 2021
Figure 17. North America PARP Inhibitor Biomarkers Service Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America PARP Inhibitor Biomarkers Service Market Size Market Share by Type (2017-2028)
Figure 19. North America PARP Inhibitor Biomarkers Service Market Size Market Share by Application (2017-2028)
Figure 20. North America PARP Inhibitor Biomarkers Service Market Size Share by Country (2017-2028)
Figure 21. United States PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe PARP Inhibitor Biomarkers Service Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe PARP Inhibitor Biomarkers Service Market Size Market Share by Type (2017-2028)
Figure 25. Europe PARP Inhibitor Biomarkers Service Market Size Market Share by Application (2017-2028)
Figure 26. Europe PARP Inhibitor Biomarkers Service Market Size Share by Country (2017-2028)
Figure 27. Germany PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific PARP Inhibitor Biomarkers Service Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific PARP Inhibitor Biomarkers Service Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific PARP Inhibitor Biomarkers Service Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific PARP Inhibitor Biomarkers Service Market Size Share by Region (2017-2028)
Figure 37. China PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America PARP Inhibitor Biomarkers Service Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America PARP Inhibitor Biomarkers Service Market Size Market Share by Type (2017-2028)
Figure 45. Latin America PARP Inhibitor Biomarkers Service Market Size Market Share by Application (2017-2028)
Figure 46. Latin America PARP Inhibitor Biomarkers Service Market Size Share by Country (2017-2028)
Figure 47. Mexico PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa PARP Inhibitor Biomarkers Service Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa PARP Inhibitor Biomarkers Service Market Size Share by Country (2017-2028)
Figure 53. Turkey PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE PARP Inhibitor Biomarkers Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Myriad Genetics, Inc. Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2017-2022)
Figure 57. Hoffmann-La Roche AG Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2017-2022)
Figure 58. Invitae Corporation Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2017-2022)
Figure 59. NeoGenomics Laboratories, Inc. Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2017-2022)
Figure 60. BPS Bioscience, Inc. Revenue Growth Rate in PARP Inhibitor Biomarkers Service Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount